Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Artificial Vital Organs and Medical Bionics Market by Type (Artificial Organs, Medical Bionics) , by Technology (Mechanical, Electronic) : Global Opportunity Analysis and Industry Forecast, 2024-2033

A00270

Pages: 280

Charts: 53

Tables: 107

Artificial Vital Organs and Medical Bionics Market Research, 2033

The global artificial vital organs and medical bionics market was valued at $47.4 billion in 2023, and is projected to reach $99.0 billion by 2033, growing at a CAGR of 7.6% from 2024 to 2033. Increasing prevalence of chronic diseases, surge in demand for organ transplants is the driving factor for the market growth.

Market Introduction and Definition 

Artificial organs and bionic implants are medical devices designed to replace or augment the function of natural organs or body parts that are damaged, dysfunctional, or missing. These devices utilize advanced technology and engineering principles to restore or enhance bodily functions, improve quality of life, and provide therapeutic benefits to individuals with medical conditions or disabilities. Artificial organs are man-made devices that replicate the structure and function of specific organs in the body. Bionic implants, on the other hand, are electronic or mechanical devices that are implanted within or attached to the body to enhance or restore specific functions. Bionic implants combine biological and technological elements to interface with the body's natural systems and provide additional capabilities. 

Key Takeaways 

  • The artificial vital organs and medical bionics size study covers 20 countries. The research includes a segment analysis of each country in terms of value ($Million) for the projected period 2023-2032. 
  • More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major artificial vital organs and medical bionics industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights. 
  • The study integrated high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach is intended to provide a balanced view of global markets and to assist stakeholders in making educated decisions in order to achieve their most ambitious artificial vital organs market objectives. 

 Key Market Segments

  • By Type
    • Artificial Organs
      • Artificial Heart
      • Artificial Kidney
      • Artificial Lungs
      • Others
    • Medical Bionics
      • Orthopedic Bionics
      • Others
  • By Technology
    • Mechanical
    • Electronic
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • Edwards Lifesciences Corporation
  • Johnson & Johnson
  • Abbott Laboratories, Inc.
  • SynCardia Systems LLC
  • Cochlear Limited
  • Berlin Heart GmbH
  • Jarvik Heart, Inc.
  • Boston Scientific Corporation
  • Zimmer Biomet Holding Inc.
  • Medtronic Plc.

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Artificial Organs

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

      • 4.2.4. Artificial Heart

        • 4.2.4.1. Market Size and Forecast

      • 4.2.4. Artificial Kidney

        • 4.2.4.1. Market Size and Forecast

      • 4.2.4. Artificial Lungs

        • 4.2.4.1. Market Size and Forecast

      • 4.2.4. Others

        • 4.2.4.1. Market Size and Forecast

    • 4.3. Medical Bionics

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

      • 4.3.4. Orthopedic Bionics

        • 4.3.4.1. Market Size and Forecast

      • 4.3.4. Others

        • 4.3.4.1. Market Size and Forecast

  • CHAPTER 5: ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TECHNOLOGY

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Technology

    • 5.2. Mechanical

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Electronic

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

  • CHAPTER 6: ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Type

      • 6.2.3. Market Size and Forecast, By Technology

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Artificial Vital Organs And Medical Bionics Market

        • 6.2.5.1. Market Size and Forecast, By Type
        • 6.2.5.2. Market Size and Forecast, By Technology

      • 6.2.6. Canada Artificial Vital Organs And Medical Bionics Market

        • 6.2.6.1. Market Size and Forecast, By Type
        • 6.2.6.2. Market Size and Forecast, By Technology

      • 6.2.7. Mexico Artificial Vital Organs And Medical Bionics Market

        • 6.2.7.1. Market Size and Forecast, By Type
        • 6.2.7.2. Market Size and Forecast, By Technology

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Type

      • 6.3.3. Market Size and Forecast, By Technology

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Artificial Vital Organs And Medical Bionics Market

        • 6.3.5.1. Market Size and Forecast, By Type
        • 6.3.5.2. Market Size and Forecast, By Technology

      • 6.3.6. Germany Artificial Vital Organs And Medical Bionics Market

        • 6.3.6.1. Market Size and Forecast, By Type
        • 6.3.6.2. Market Size and Forecast, By Technology

      • 6.3.7. Italy Artificial Vital Organs And Medical Bionics Market

        • 6.3.7.1. Market Size and Forecast, By Type
        • 6.3.7.2. Market Size and Forecast, By Technology

      • 6.3.8. Spain Artificial Vital Organs And Medical Bionics Market

        • 6.3.8.1. Market Size and Forecast, By Type
        • 6.3.8.2. Market Size and Forecast, By Technology

      • 6.3.9. UK Artificial Vital Organs And Medical Bionics Market

        • 6.3.9.1. Market Size and Forecast, By Type
        • 6.3.9.2. Market Size and Forecast, By Technology

      • 6.3.10. Russia Artificial Vital Organs And Medical Bionics Market

        • 6.3.10.1. Market Size and Forecast, By Type
        • 6.3.10.2. Market Size and Forecast, By Technology

      • 6.3.11. Rest Of Europe Artificial Vital Organs And Medical Bionics Market

        • 6.3.11.1. Market Size and Forecast, By Type
        • 6.3.11.2. Market Size and Forecast, By Technology

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Type

      • 6.4.3. Market Size and Forecast, By Technology

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Artificial Vital Organs And Medical Bionics Market

        • 6.4.5.1. Market Size and Forecast, By Type
        • 6.4.5.2. Market Size and Forecast, By Technology

      • 6.4.6. Japan Artificial Vital Organs And Medical Bionics Market

        • 6.4.6.1. Market Size and Forecast, By Type
        • 6.4.6.2. Market Size and Forecast, By Technology

      • 6.4.7. India Artificial Vital Organs And Medical Bionics Market

        • 6.4.7.1. Market Size and Forecast, By Type
        • 6.4.7.2. Market Size and Forecast, By Technology

      • 6.4.8. South Korea Artificial Vital Organs And Medical Bionics Market

        • 6.4.8.1. Market Size and Forecast, By Type
        • 6.4.8.2. Market Size and Forecast, By Technology

      • 6.4.9. Australia Artificial Vital Organs And Medical Bionics Market

        • 6.4.9.1. Market Size and Forecast, By Type
        • 6.4.9.2. Market Size and Forecast, By Technology

      • 6.4.10. Thailand Artificial Vital Organs And Medical Bionics Market

        • 6.4.10.1. Market Size and Forecast, By Type
        • 6.4.10.2. Market Size and Forecast, By Technology

      • 6.4.11. Malaysia Artificial Vital Organs And Medical Bionics Market

        • 6.4.11.1. Market Size and Forecast, By Type
        • 6.4.11.2. Market Size and Forecast, By Technology

      • 6.4.12. Indonesia Artificial Vital Organs And Medical Bionics Market

        • 6.4.12.1. Market Size and Forecast, By Type
        • 6.4.12.2. Market Size and Forecast, By Technology

      • 6.4.13. Rest of Asia Pacific Artificial Vital Organs And Medical Bionics Market

        • 6.4.13.1. Market Size and Forecast, By Type
        • 6.4.13.2. Market Size and Forecast, By Technology

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Type

      • 6.5.3. Market Size and Forecast, By Technology

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Artificial Vital Organs And Medical Bionics Market

        • 6.5.5.1. Market Size and Forecast, By Type
        • 6.5.5.2. Market Size and Forecast, By Technology

      • 6.5.6. South Africa Artificial Vital Organs And Medical Bionics Market

        • 6.5.6.1. Market Size and Forecast, By Type
        • 6.5.6.2. Market Size and Forecast, By Technology

      • 6.5.7. Saudi Arabia Artificial Vital Organs And Medical Bionics Market

        • 6.5.7.1. Market Size and Forecast, By Type
        • 6.5.7.2. Market Size and Forecast, By Technology

      • 6.5.8. UAE Artificial Vital Organs And Medical Bionics Market

        • 6.5.8.1. Market Size and Forecast, By Type
        • 6.5.8.2. Market Size and Forecast, By Technology

      • 6.5.9. Argentina Artificial Vital Organs And Medical Bionics Market

        • 6.5.9.1. Market Size and Forecast, By Type
        • 6.5.9.2. Market Size and Forecast, By Technology

      • 6.5.10. Rest of LAMEA Artificial Vital Organs And Medical Bionics Market

        • 6.5.10.1. Market Size and Forecast, By Type
        • 6.5.10.2. Market Size and Forecast, By Technology

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. SynCardia Systems LLC

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Abbott Laboratories, Inc.

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Cochlear Limited

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Boston Scientific Corporation

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Johnson And Johnson

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Edwards Lifesciences Corporation

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Zimmer Biomet Holding Inc.

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Berlin Heart GmbH

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Jarvik Heart, Inc.

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Medtronic Plc.

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET FOR ARTIFICIAL ORGANS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET FOR MEDICAL BIONICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET FOR MECHANICAL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET FOR ELECTRONIC, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. NORTH AMERICA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. NORTH AMERICA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 10. NORTH AMERICA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 11. U.S. ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 12. U.S. ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 13. CANADA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 14. CANADA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 15. MEXICO ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 16. MEXICO ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 17. EUROPE ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 18. EUROPE ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 19. EUROPE ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 20. FRANCE ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 21. FRANCE ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 22. GERMANY ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 23. GERMANY ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 24. ITALY ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 25. ITALY ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 26. SPAIN ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 27. SPAIN ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 28. UK ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 29. UK ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 30. RUSSIA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 31. RUSSIA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 32. REST OF EUROPE ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 33. REST OF EUROPE ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 34. ASIA-PACIFIC ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 35. ASIA-PACIFIC ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 36. ASIA-PACIFIC ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 37. CHINA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 38. CHINA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 39. JAPAN ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 40. JAPAN ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 41. INDIA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 42. INDIA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 43. SOUTH KOREA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 44. SOUTH KOREA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 45. AUSTRALIA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 46. AUSTRALIA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 47. THAILAND ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 48. THAILAND ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 49. MALAYSIA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 50. MALAYSIA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 51. INDONESIA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 52. INDONESIA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 53. REST OF ASIA PACIFIC ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 54. REST OF ASIA PACIFIC ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 55. LAMEA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 56. LAMEA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 57. LAMEA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 58. BRAZIL ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 59. BRAZIL ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 60. SOUTH AFRICA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 61. SOUTH AFRICA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 62. SAUDI ARABIA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 63. SAUDI ARABIA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 64. UAE ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 65. UAE ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 66. ARGENTINA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 67. ARGENTINA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 68. REST OF LAMEA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 69. REST OF LAMEA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 70. SYNCARDIA SYSTEMS LLC: KEY EXECUTIVES
  • TABLE 71. SYNCARDIA SYSTEMS LLC: COMPANY SNAPSHOT
  • TABLE 72. SYNCARDIA SYSTEMS LLC: OPERATING SEGMENTS
  • TABLE 73. SYNCARDIA SYSTEMS LLC: PRODUCT PORTFOLIO
  • TABLE 74. SYNCARDIA SYSTEMS LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 75. ABBOTT LABORATORIES, INC.: KEY EXECUTIVES
  • TABLE 76. ABBOTT LABORATORIES, INC.: COMPANY SNAPSHOT
  • TABLE 77. ABBOTT LABORATORIES, INC.: OPERATING SEGMENTS
  • TABLE 78. ABBOTT LABORATORIES, INC.: PRODUCT PORTFOLIO
  • TABLE 79. ABBOTT LABORATORIES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 80. COCHLEAR LIMITED: KEY EXECUTIVES
  • TABLE 81. COCHLEAR LIMITED: COMPANY SNAPSHOT
  • TABLE 82. COCHLEAR LIMITED: OPERATING SEGMENTS
  • TABLE 83. COCHLEAR LIMITED: PRODUCT PORTFOLIO
  • TABLE 84. COCHLEAR LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 85. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
  • TABLE 86. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 87. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
  • TABLE 88. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 89. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 90. JOHNSON AND JOHNSON: KEY EXECUTIVES
  • TABLE 91. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
  • TABLE 92. JOHNSON AND JOHNSON: OPERATING SEGMENTS
  • TABLE 93. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
  • TABLE 94. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 95. EDWARDS LIFESCIENCES CORPORATION: KEY EXECUTIVES
  • TABLE 96. EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
  • TABLE 97. EDWARDS LIFESCIENCES CORPORATION: OPERATING SEGMENTS
  • TABLE 98. EDWARDS LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO
  • TABLE 99. EDWARDS LIFESCIENCES CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 100. ZIMMER BIOMET HOLDING INC.: KEY EXECUTIVES
  • TABLE 101. ZIMMER BIOMET HOLDING INC.: COMPANY SNAPSHOT
  • TABLE 102. ZIMMER BIOMET HOLDING INC.: OPERATING SEGMENTS
  • TABLE 103. ZIMMER BIOMET HOLDING INC.: PRODUCT PORTFOLIO
  • TABLE 104. ZIMMER BIOMET HOLDING INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 105. BERLIN HEART GMBH: KEY EXECUTIVES
  • TABLE 106. BERLIN HEART GMBH: COMPANY SNAPSHOT
  • TABLE 107. BERLIN HEART GMBH: OPERATING SEGMENTS
  • TABLE 108. BERLIN HEART GMBH: PRODUCT PORTFOLIO
  • TABLE 109. BERLIN HEART GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 110. JARVIK HEART, INC.: KEY EXECUTIVES
  • TABLE 111. JARVIK HEART, INC.: COMPANY SNAPSHOT
  • TABLE 112. JARVIK HEART, INC.: OPERATING SEGMENTS
  • TABLE 113. JARVIK HEART, INC.: PRODUCT PORTFOLIO
  • TABLE 114. JARVIK HEART, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 115. MEDTRONIC PLC.: KEY EXECUTIVES
  • TABLE 116. MEDTRONIC PLC.: COMPANY SNAPSHOT
  • TABLE 117. MEDTRONIC PLC.: OPERATING SEGMENTS
  • TABLE 118. MEDTRONIC PLC.: PRODUCT PORTFOLIO
  • TABLE 119. MEDTRONIC PLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET
  • FIGURE 3. SEGMENTATION ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET
  • FIGURE 11. ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET FOR ARTIFICIAL ORGANS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET FOR MEDICAL BIONICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET SEGMENTATION, BY BY TECHNOLOGY
  • FIGURE 15. ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET FOR MECHANICAL, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET FOR ELECTRONIC, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 18. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 19. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 20. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 21. COMPETITIVE DASHBOARD
  • FIGURE 22. COMPETITIVE HEATMAP: ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET
  • FIGURE 23. TOP PLAYER POSITIONING, 2024
  • FIGURE 24. SYNCARDIA SYSTEMS LLC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 25. SYNCARDIA SYSTEMS LLC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 26. SYNCARDIA SYSTEMS LLC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 27. ABBOTT LABORATORIES, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 28. ABBOTT LABORATORIES, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 29. ABBOTT LABORATORIES, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 30. COCHLEAR LIMITED: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 31. COCHLEAR LIMITED: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 32. COCHLEAR LIMITED: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 33. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 34. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 35. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 36. JOHNSON AND JOHNSON: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 37. JOHNSON AND JOHNSON: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 38. JOHNSON AND JOHNSON: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 39. EDWARDS LIFESCIENCES CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 40. EDWARDS LIFESCIENCES CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 41. EDWARDS LIFESCIENCES CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 42. ZIMMER BIOMET HOLDING INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 43. ZIMMER BIOMET HOLDING INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 44. ZIMMER BIOMET HOLDING INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 45. BERLIN HEART GMBH: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 46. BERLIN HEART GMBH: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 47. BERLIN HEART GMBH: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 48. JARVIK HEART, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 49. JARVIK HEART, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 50. JARVIK HEART, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 51. MEDTRONIC PLC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 52. MEDTRONIC PLC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 53. MEDTRONIC PLC.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Artificial Vital Organs and Medical Bionics Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved